On Tuesday, Autolus Therapeutics plc ADR (NASDAQ: AUTL) was 13.64% up from the session before settling in for the closing price of $1.32. A 52-week range for AUTL has been $1.11 – $3.99.
Healthcare Sector giant saw their annual sales surged by 21.35% over the last five years. When this article was written, the company’s average yearly earnings per share was at 3.04%. With a float of $240.31 million, this company’s outstanding shares have now reached $266.14 million.
Autolus Therapeutics plc ADR (AUTL) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Autolus Therapeutics plc ADR stocks. The insider ownership of Autolus Therapeutics plc ADR is 9.71%, while institutional ownership is 58.64%.
Autolus Therapeutics plc ADR (AUTL) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.31 earnings per share (EPS) during the time that was less than consensus figure (set at -0.22) by -0.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.27% during the next five years compared to 21.35% growth over the previous five years of trading.
Autolus Therapeutics plc ADR (NASDAQ: AUTL) Trading Performance Indicators
You can see what Autolus Therapeutics plc ADR (AUTL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.86, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Autolus Therapeutics plc ADR (AUTL)
Analysing the last 5-days average volume posted by the [Autolus Therapeutics plc ADR, AUTL], we can find that recorded value of 2.19 million was lower than the volume posted last year of 2.35 million. As of the previous 9 days, the stock’s Stochastic %D was 32.93%.
During the past 100 days, Autolus Therapeutics plc ADR’s (AUTL) raw stochastic average was set at 16.67%, which indicates a significant decrease from 59.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0989 in the past 14 days, which was lower than the 0.1205 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5082, while its 200-day Moving Average is $1.7924. Now, the first resistance to watch is $1.5667. This is followed by the second major resistance level at $1.6333. The third major resistance level sits at $1.7467. If the price goes on to break the first support level at $1.3867, it is likely to go to the next support level at $1.2733. Should the price break the second support level, the third support level stands at $1.2067.
Autolus Therapeutics plc ADR (NASDAQ: AUTL) Key Stats
There are 266,141K outstanding shares of the company, which has a market capitalization of 399.21 million. As of now, sales total 10,120 K while income totals -220,660 K. Its latest quarter income was 20,920 K while its last quarter net income were -47,920 K.
